CPAP-THERAPY DECREASES GLYCATED HEMOGLOBIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND SLEEP APNOEA
Among the Type 2 Diabetes Mellitus (Type 2 DB) patients obstructive sleep apnoea (OSA) syndrome, which adversely affects the state of carbohydrate exchange and the quality of sleep, is widespread. The standard for the treatment of OSA is CPAP therapy. In this retrospective cohort study, the influenc...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2017-05-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/1880 |
Summary: | Among the Type 2 Diabetes Mellitus (Type 2 DB) patients obstructive sleep apnoea (OSA) syndrome, which adversely affects the state of carbohydrate exchange and the quality of sleep, is widespread. The standard for the treatment of OSA is CPAP therapy. In this retrospective cohort study, the influence of CPAP-therapy on the level of glycosylated haemoglobin (HbA1c) was assessed in the 34 second-type SR patients receiving sugar-reducing therapy. As a result of 3 months of treatment, there has been a decrease of HbA1c by 0.7%, the disappearance of day sleepiness, and the overwhelming majority of normalization of the quality of sleep. Thus, with the combination of the Type 2 DM and the OSA of medium or heavy degree, CPAP therapy has an independent beneficial effect on the state of carbohydrate exchange. |
---|---|
ISSN: | 2079-701X 2658-5790 |